Trade Report: Today, Corindus Vascular Robotics Inc (CVRS) Rating Increased to Hold at The Zacks Investment Research

Today, Corindus Vascular Robotics Inc (CVRS) Rating Increased to Hold at The Zacks Investment Research

Zacks Investment Research upgraded shares of Corindus Vascular Robotics Inc (NYSEMKT:CVRS) from a sell rating to a hold rating in a research report sent to investors on Monday morning.

According to Zacks, “Corindus Vascular Robotics, Inc. is involved in designing, manufacturing and selling precision vascular robotic-assisted systems for interventional vascular procedures. The Company’s product includes CorPath 200 system a vascular robotic system which provide stent placement in percutaneous coronary intervention procedures. Corindus Vascular Robotics, Inc. is based in Waltham, Massachusetts. “

Separately, B. Riley reiterated a buy rating and set a $3.00 target price on shares of Corindus Vascular Robotics in a research report on Monday, November 14th.

Shares of Corindus Vascular Robotics (NYSEMKT:CVRS) opened at 0.77 on Monday. The firm’s market cap is $91.65 million. Corindus Vascular Robotics has a 52 week low of $0.73 and a 52 week high of $3.50. The firm’s 50 day moving average is $0.90 and its 200-day moving average is $1.19.

Corindus Vascular Robotics (NYSEMKT:CVRS) last announced its earnings results on Tuesday, November 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.06) by $0.01. Equities research analysts predict that Corindus Vascular Robotics will post ($0.26) EPS for the current year.

Several large investors have recently bought and sold shares of CVRS. Schwab Charles Investment Management Inc. increased its stake in shares of Corindus Vascular Robotics by 236.0% in the second quarter. Schwab Charles Investment Management Inc. now owns 84,000 shares of the company’s stock valued at $121,000 after buying an additional 59,000 shares during the last quarter. California State Teachers Retirement System increased its stake in shares of Corindus Vascular Robotics by 139.3% in the second quarter. California State Teachers Retirement System now owns 115,258 shares of the company’s stock valued at $165,000 after buying an additional 67,091 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Corindus Vascular Robotics by 44.4% in the second quarter. Bank of New York Mellon Corp now owns 164,570 shares of the company’s stock valued at $235,000 after buying an additional 50,636 shares during the last quarter. BlackRock Investment Management LLC increased its stake in shares of Corindus Vascular Robotics by 128.5% in the second quarter. BlackRock Investment Management LLC now owns 178,093 shares of the company’s stock valued at $255,000 after buying an additional 100,170 shares during the last quarter. Finally, State Street Corp increased its stake in shares of Corindus Vascular Robotics by 12.3% in the second quarter. State Street Corp now owns 258,877 shares of the company’s stock valued at $369,000 after buying an additional 28,377 shares during the last quarter.

About Corindus Vascular Robotics

Related posts

Leave a Comment